forty-eight neutropenic patients with acute leukaemia were randomly allocated to receive , as antifungal prophylaxis , either ketoconazole , 400 mg once daily ( k ) , or amphotericin b tablets and lozenges ( a ) , or both ketoconazole and amphotericin b together ( k + a ) .
C0003308
antifungal
C0002679
amphotericin b